- Home
- CTSO vs CNVS Comparison
CTSO vs CNVS Comparison
Compare CTSO & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- CNVS
- Stock Information
- Founded
- CTSO 1997
- CNVS 2000
- Country
- CTSO United States
- CNVS United States
- Employees
- CTSO N/A
- CNVS N/A
- Industry
- CTSO Medical/Dental Instruments
- CNVS Consumer Electronics/Video Chains
- Sector
- CTSO Health Care
- CNVS Consumer Discretionary
- Exchange
- CTSO Nasdaq
- CNVS Nasdaq
- Market Cap
- CTSO 51.6M
- CNVS 56.2M
- IPO Year
- CTSO N/A
- CNVS 2003
- Fundamental
- Price
- CTSO $1.03
- CNVS $3.54
- Analyst Decision
- CTSO Strong Buy
- CNVS Buy
- Analyst Count
- CTSO 3
- CNVS 1
- Target Price
- CTSO $4.67
- CNVS $10.00
- AVG Volume (30 Days)
- CTSO 538.8K
- CNVS 104.5K
- Earning Date
- CTSO 03-06-2025
- CNVS 02-12-2025
- Dividend Yield
- CTSO N/A
- CNVS N/A
- EPS Growth
- CTSO N/A
- CNVS N/A
- EPS
- CTSO N/A
- CNVS N/A
- Revenue
- CTSO $37,739,531.00
- CNVS $45,005,000.00
- Revenue This Year
- CTSO $9.20
- CNVS $50.96
- Revenue Next Year
- CTSO $11.64
- CNVS N/A
- P/E Ratio
- CTSO N/A
- CNVS N/A
- Revenue Growth
- CTSO 1.80
- CNVS N/A
- 52 Week Low
- CTSO $0.70
- CNVS $0.72
- 52 Week High
- CTSO $1.59
- CNVS $4.19
- Technical
- Relative Strength Index (RSI)
- CTSO 55.82
- CNVS 49.00
- Support Level
- CTSO $1.00
- CNVS $3.34
- Resistance Level
- CTSO $1.14
- CNVS $3.60
- Average True Range (ATR)
- CTSO 0.09
- CNVS 0.23
- MACD
- CTSO 0.01
- CNVS -0.05
- Stochastic Oscillator
- CTSO 64.40
- CNVS 28.57
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. It operates portfolios of owned and operated streaming channels, all powered by its, proprietary technology platform. Cineverse features enthusiast brands for subscription video on demand (SVOD), advertising-based video on demand (AVOD), and free, ad-supported streaming television (FAST) channels. The company earns fees for the distribution of content in the home entertainment markets via several distribution channels, including digital, video-on-demand, and physical goods (e.g., DVDs and Blu-ray Discs) (Base Distribution).